Design of lipotomes as a novel dual functioning nanocarrier for bioavailability enhancement of lacidipine: In-vitro and in-vivo characterization

被引:36
作者
ElKasabgy, Nermeen Adel [1 ]
Elsayed, Ibrahim [1 ]
Elshafeey, Ahmed Hassen [1 ,2 ]
机构
[1] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo 11562, Egypt
[2] Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada
关键词
Lipotomes; Lacidipine; Central composite; Lyophilization; Enteric coating; SOLID LIPID NANOPARTICLES; 1ST-PASS ELIMINATION; MIXED MICELLES; SOLUBLE DRUGS; DELIVERY; OPTIMIZATION; FORMULATION; SOLUBILIZATION; HYDROCHLORIDE; VINPOCETINE;
D O I
10.1016/j.ijpharm.2014.06.048
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lipotomes were designed to enhance lacidipine's oral bioavailability by improving its solubility and enhancing the oral lymphatic uptake. Lipotomes were prepared using cetyl alcohol and Tween (R) 80 using a thin film hydration technique. Cetyl alcohol was chosen for imparting a lipophilic environment that would enforce the lymphatic uptake while Tween (R) 80 would improve drug solubility within the lipotomes. Lipotomes were characterized by analyzing their particle size, solubilization efficiency and in-vitro drug release. Central composite design was applied to statistically optimize the formulations using Design-Expert (R) software. The optimum formula (OLT) was made up of excipients: drug ratio of 36.59:1 w/w and Tween (R) 80:cetyl alcohol ratio of 4:1 w/w. OLT was lyophilized and filled into Eudragit (R) L100 enteric coated capsules. Mannitol (10% w/v) was the ideal cryoprotectant to retain the physicochemical characteristics of the OLT formulation after lyophilization. In conclusion, the selected lyophilized formula (L3) succeeded in enhancing drug's oral bioavailability in human volunteers compared to the commercial product confirming the success of lipotomes as a novel oral nanocarrier for insoluble drugs having extensive first pass metabolism. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:369 / 379
页数:11
相关论文
共 48 条
[1]   Freeze-drying of nanoparticles: Formulation, process and storage considerations [J].
Abdelwahed, Wassim ;
Degobert, Ghania ;
Stainmesse, Serge ;
Fessi, Hatem .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (15) :1688-1713
[2]  
Alexander J S, 2010, Pathophysiology, V17, P315, DOI 10.1016/j.pathophys.2009.09.003
[3]  
[Anonymous], 2008, OPEN MOL J
[4]   Physicochemical properties of enteric films prepared from aqueous dispersions and organic solutions [J].
Bando, H ;
McGinity, JW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 313 (1-2) :43-48
[5]   DIFFUSION OF UNIVALENT IONS ACROSS LAMELLAE OF SWOLLEN PHOSPHOLIPIDS [J].
BANGHAM, AD ;
STANDISH, MM ;
WATKINS, JC .
JOURNAL OF MOLECULAR BIOLOGY, 1965, 13 (01) :238-+
[6]   SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: Development and optimization [J].
Basalious, Emad B. ;
Shawky, Nevine ;
Badr-Eldin, Shaimaa M. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 391 (1-2) :203-211
[7]   Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol [J].
Basavaraj, Siddalingappa ;
Betageri, Guru V. .
EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (04) :493-503
[8]  
BEAUBIEN AR, 1979, DRUG METAB DISPOS, V7, P34
[9]   Lipophilic prodrugs designed for intestinal lymphatic transport [J].
Charman, WN ;
Porter, CJH .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 19 (02) :149-169
[10]  
Commission BP, 2008, BRIT PHARMACOPOEIA